CurveBeam AI (ASX:CVB) Issuance of Debt : A$0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is CurveBeam AI Issuance of Debt?

CurveBeam AI's Issuance of Debt for the six months ended in Dec. 2023 was A$0.00 Mil.

CurveBeam AI's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00 Mil.

CurveBeam AI Issuance of Debt Historical Data

The historical data trend for CurveBeam AI's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CurveBeam AI Issuance of Debt Chart

CurveBeam AI Annual Data

Trend

Jun21

Jun22

Jun23

Issuance of Debt

0.59

15.90

0.12

CurveBeam AI Semi-Annual Data
	Jun21	Dec21	Jun22	Jun23	Dec23
Issuance of Debt	-	-	-	-	-

CurveBeam AI Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

CurveBeam AI Issuance of Debt Related Terms

Thank you for viewing the detailed overview of CurveBeam AI's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

CurveBeam AI (ASX:CVB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CurveBeam AI Ltd (ASX:CVB) » Definitions » Issuance of Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

10?16 Queen Street, Level 10, Melbourne, VIC, AUS, 3000

Website

https://www.curvebeamai.com

CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the Company's CT devices to assist in the clinical assessment and management of musculoskeletal health conditions, with a focus on orthopedic and bone health issues. The Company is the first to market with natural bilateral weight-bearing and non-weight-bearing CT, point-of-care imaging equipment with targeted proprietary AI solutions.

CurveBeam AI (ASX:CVB) Headlines

No Headlines